Image

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

To measure coronary calcium score in adults treated during childhood or adolescence for irradiation cancer in the heart and / or anthracycline area and compare them to determine whether irradiation of the heart area is associated with increased calcium score after adjustment for other cardiovascular risk factors (age, sex, smoking, dyslipidemia, obesity, diabetes, high blood pressure and renal failure).

Eligibility

Inclusion Criteria:

  1. Patients 18 years of age or older,
  2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years),
  3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate) and / or anthracycline (cumulative dose of doxorubicin equivalent ≥300mg/m\^²),
  4. In complete remission of their pediatric cancer for at least 10 years,
  5. Patient affiliated to a social security scheme or beneficiary of such a scheme,
  6. Patient Information and Signed Informed Consent.

Exclusion Criteria:

  1. Perspective less than 10 years,
  2. Persons deprived of liberty or guardianship (including trusteeship),
  3. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons,
  4. Pregnant women.

Inclusion criteria for extension cohort:

  1. Patients 30 years of age or older,
  2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years),
  3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate),
  4. In complete remission of their pediatric cancer for at least 10 years,
  5. Patient affiliated to a social security scheme or beneficiary of such a scheme,
  6. Patient Information and Signed Informed Consent.

Exclusion criteria for extension cohort:

  1. Persons deprived of liberty or guardianship (including trusteeship),
  2. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons,
  3. Pregnant women.

Study details
    Childhood Cancer

NCT03604627

Gustave Roussy, Cancer Campus, Grand Paris

14 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.